Anhui Anke BioTech Group (300009) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Anhui Anke BioTech Group (300009) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥240.51 Million ≈ $35.19 Million USD) by net assets (CN¥4.34 Billion ≈ $635.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300009 market cap for the company's overall valuation and market capitalisation.

Anhui Anke BioTech Group - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Anhui Anke BioTech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anhui Anke BioTech Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Anke BioTech Group ranked by their cash flow conversion efficiency. Explore Anhui Anke BioTech Group cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
0.048x
Telecom Argentina
BA:TECO2
0.156x
Jindal Saw Limited
NSE:JINDALSAW
-0.025x
Jiangsu Leili Motor Corp Ltd
SHE:300660
0.022x
Batu Kawan Bhd
KLSE:1899
-0.060x
Hangzhou Steam Turbine
SHE:200771
0.014x
BWP Trust
AU:BWP
0.020x
Sichuan Teway Food Group Co Ltd
SHG:603317
0.081x

Annual Cash Flow Conversion Efficiency for Anhui Anke BioTech Group (2006–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Anke BioTech Group from 2006 to 2025. View Anhui Anke BioTech Group share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.74 Billion
≈ $693.08 Million
CN¥863.22 Million
≈ $126.32 Million
0.182x +14.34%
2024-12-31 CN¥4.30 Billion
≈ $629.22 Million
CN¥685.37 Million
≈ $100.29 Million
0.159x -34.23%
2023-12-31 CN¥3.93 Billion
≈ $575.42 Million
CN¥952.97 Million
≈ $139.45 Million
0.242x +17.94%
2022-12-31 CN¥3.40 Billion
≈ $497.77 Million
CN¥698.98 Million
≈ $102.28 Million
0.205x +0.75%
2021-12-31 CN¥2.90 Billion
≈ $424.88 Million
CN¥592.17 Million
≈ $86.65 Million
0.204x +28.50%
2020-12-31 CN¥2.93 Billion
≈ $428.54 Million
CN¥464.80 Million
≈ $68.01 Million
0.159x +44.95%
2019-12-31 CN¥2.70 Billion
≈ $395.10 Million
CN¥295.63 Million
≈ $43.26 Million
0.109x -23.41%
2018-12-31 CN¥2.01 Billion
≈ $294.29 Million
CN¥287.49 Million
≈ $42.07 Million
0.143x -10.32%
2017-12-31 CN¥1.76 Billion
≈ $257.60 Million
CN¥280.63 Million
≈ $41.06 Million
0.159x -11.88%
2016-12-31 CN¥1.43 Billion
≈ $208.70 Million
CN¥258.01 Million
≈ $37.75 Million
0.181x +92.66%
2015-12-31 CN¥1.26 Billion
≈ $185.03 Million
CN¥118.73 Million
≈ $17.37 Million
0.094x -33.17%
2014-12-31 CN¥773.47 Million
≈ $113.18 Million
CN¥108.68 Million
≈ $15.90 Million
0.141x +74.44%
2013-12-31 CN¥660.60 Million
≈ $96.67 Million
CN¥53.21 Million
≈ $7.79 Million
0.081x -13.16%
2012-12-31 CN¥580.03 Million
≈ $84.88 Million
CN¥53.80 Million
≈ $7.87 Million
0.093x +602.56%
2011-12-31 CN¥543.88 Million
≈ $79.59 Million
CN¥7.18 Million
≈ $1.05 Million
0.013x -85.46%
2010-12-31 CN¥522.30 Million
≈ $76.43 Million
CN¥47.43 Million
≈ $6.94 Million
0.091x +16.32%
2009-12-31 CN¥495.41 Million
≈ $72.49 Million
CN¥38.67 Million
≈ $5.66 Million
0.078x -55.44%
2008-12-31 CN¥148.64 Million
≈ $21.75 Million
CN¥26.04 Million
≈ $3.81 Million
0.175x -31.56%
2007-12-31 CN¥137.09 Million
≈ $20.06 Million
CN¥35.10 Million
≈ $5.14 Million
0.256x +5.30%
2006-12-31 CN¥122.00 Million
≈ $17.85 Million
CN¥29.66 Million
≈ $4.34 Million
0.243x --

About Anhui Anke BioTech Group

SHE:300009 China Biotechnology
Market Cap
$1.99 Billion
CN¥13.63 Billion CNY
Market Cap Rank
#6213 Global
#1211 in China
Share Price
CN¥8.16
Change (1 day)
+0.99%
52-Week Range
CN¥7.50 - CN¥11.23
All Time High
CN¥127.71
About

Anhui Anke Biotechnology (Group) Co., Ltd. engages in the biopharmaceutical industry in China and internationally. It offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name… Read more